DURHAM, N.C., Sept. 9 /PRNewswire-FirstCall/ -- Oxygen Biotherapeutics, Inc. announced that the company's proxy, which is being mailed today, asks shareholders to approve a 1-for-15 reverse stock split at the annual meeting on Oct. 19, 2009.
At the meeting, shareholders also will vote on the election of six directors. The current directors have been nominated by the Board for re-election.
About Oxygen Biotherapeutics, Inc.
Oxygen Biotherapeutics, Inc.
